The supercomputers will run a myriad of calculations in epidemiology, bioinformatics and molecular modelling, in a bid to drastically cut the time of discovery of new molecules that could lead to a vaccine. Having received proposals from all over the world, we have already reviewed, approved and matched 15 projects to the right supercomputers. More will follow.